Author Question: One of the eligibility criteria for deaf-blindness is that the student's disability has an adverse ... (Read 159 times)

tatyanajohnson

  • Hero Member
  • *****
  • Posts: 569
One of the eligibility criteria for deaf-blindness is that the student's disability has an adverse impact on the student's educational performance when the student is at the age of eligibility for kindergarten through age 21, or has an adverse impact on the student's developmental progress when the student is age three through kindergarten.
 
  a. True
  b. False

Question 2

Which of the following is NOT an eligibility criteria for autism?
 
  a. The student exhibits impairments in communication
  b. The student exhibits an abnormal range of activities
  c. The student exhibits difficulties in forming appropriate relationships
  d. The student exhibits unusual responses to sensory information



Mollythedog

  • Sr. Member
  • ****
  • Posts: 340
Answer to Question 1

a

Answer to Question 2

b



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

The first oral chemotherapy drug for colon cancer was approved by FDA in 2001.

Did you know?

Chronic necrotizing aspergillosis has a slowly progressive process that, unlike invasive aspergillosis, does not spread to other organ systems or the blood vessels. It most often affects middle-aged and elderly individuals, spreading to surrounding tissue in the lungs. The disease often does not respond to conventionally successful treatments, and requires individualized therapies in order to keep it from becoming life-threatening.

Did you know?

Medication errors are more common among seriously ill patients than with those with minor conditions.

Did you know?

Cocaine was isolated in 1860 and first used as a local anesthetic in 1884. Its first clinical use was by Sigmund Freud to wean a patient from morphine addiction. The fictional character Sherlock Holmes was supposed to be addicted to cocaine by injection.

Did you know?

Certain topical medications such as clotrimazole and betamethasone are not approved for use in children younger than 12 years of age. They must be used very cautiously, as directed by a doctor, to treat any child. Children have a much greater response to topical steroid medications.

For a complete list of videos, visit our video library